Serum CEACAM1 levels were markedly elevated in AP patients (2.9-fold, p < 0.0001) and in RP patients (2.1-fold in average, p < 0.0001), as compared to the healthy donors. This evidence concerns the gene CEACAM1 and retinitis pigmentosa 1.